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1. Introduction 
Haemoglobin Coventry is a mildly unstable variant 
with a deletion of leucine at position 141 in what is 
chemically a B-chain, but must be considered an anti- 
Lepore /3/S fusion chain for genetical reasons [l] . It 
occurs at well below 10% in the haemolysate, and in 
haemolysates of straight forward carriers does not 
precipitate on routine lability tests for unstable 
haemoglobins. In the first case studied it was present 
together with the unstable Hb Sydney and co- 
precipitated &lability tests yielding an enriched 
sediment, and this led to its discovery. We now report 
a finding of this variant in two Iranian sisters where it 
was associated with a-thalassaemia. 
2. Methods 
Haematological investigations and determination 
of oxygen dissociation followed routine practice [2]. 
Preparation of haemolysate, electrophoresis on cel- 
lulose acetate at pH 8.9, agar gel (pH 6.0), and starch 
gel (pH 8.5), quantitation of Hb F and Hb Az, heat 
and isopropanol lability tests, preparation of globin, 
preparation of two-dimensional diagnostic and 
preparative tryptic peptide chromatograms, specific 
and ninhydrin staining of peptides, their elution and 
amino acid analysis have been summarised in [3] . 
Separation of globin chains was carried out in the 
presence of 8 M urea on CM 23 cellulose columns. [4] . 
The methods used for determining the cz/nona 
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globin synthesis ratio in reticulocytes and bone 
marrow cells have been fully described [ 1,5] . 
3. Results 
The propositus was a 36 years old Iranian woman 
from Kermanshah who came to attention because of 
a haemolytic anaemia with jaundice and hepato- 
splenomegaly which had become aggravated after a 
delivery. She was treated with iron unsuccessfully, 
but responded to folic acid treatment, and improved 
steadily. She still had a hypochromic anaemia with 
reticulocytosis associated with a normal serum iron 
level and a low percentage of Hb A*. In addition her 
blood picture was that of thalassaemia with aniso- 
cytosis, poikilocytosis and basophilic stippling. On 
the basis of these findings an a-thalassaemia was 
diagnosed. No Hb H inclusion bodies were found 
however and no Hb H was seen on electrophoresis. 
The a-thalassaemia was classified as cu-thalassaemia 
type 1 (2 a-chain genes not expressed). For details 
of the last haematological findings see table 1. The 
a/non-cY globin synthesis ratio in reticulocytes and 
bone marrow cells labelled with [3H]leucine was 
0.77 as compared with a ratio of 0.97-l .l in 4 
normal controls. This is a value expected for 
ar-thalassaemia type 1. The bone marrow showed 
erythroid hyperactivity with normoblasts and ample 
iron storage; megakaryocytes were numerous, and the 
m/e ratio was within normal limits. These findings 
again are compatible with a-thalassaemia type 1. The 
P05,-, of the peripheral blood was 19 mm Hg compared 
with 23 of a normal control, i.e. it was normal. 
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Table 1 
Haematological findings 
November 1978 
Hb RBC Reticuloc. PCV 
(g/d11 (X 10’2/l) (X 109/l) Q/H 
MCV 
(fl) 
MCH 
(Pg) 
MCHC Serum Fe Hb F Hb A, 
(g/dH (~molll) (%I (%I 
Propositus 10.0 5.03 500 0.32 63.6 19.9 31.2 25.1 0.8 1.7 
Sister 9.2 4.73 - 0.31 65.5 19.5 29.7 - - - 
3.1. Hb Covemy 
Some years ago when the anaemia of the patient 
was severe after pregnancy and delivery, an unstable 
haemoglobin disease was suspected and a 10 min iso- 
propanol precipitate was sent to Cambridge. On 
examination of the ‘fingerprint’ of the isolated 
/3-chain an additional peptide was discovered moving 
on the fingerprint with the same lectrophoretic 
mobility as flATpXIV (p 133 -144) but lying below as 
if it was more hydrophilic. Both peptides howed a 
positive reaction for histidine (fig.1). On amino acid 
analysis the companion peptide was found to have 
the same amino acid composition asPATpXIV, except 
that the residue derived from 0141 Leu was absent. 
The fingerprint and the amino acid analysis were 
identical with those found for Hb Coventry [l] . In 
the case of the original propositus Hbs Coventry and 
Sydney had co-precipitated. It was assumed that in 
this case Hb Coventry had co-precipitated with the 
haemoglobin derivatives arising from the cr-globin 
chain imbalance of cu-thalassaemia, which, though not 
giving rise to Hb H inclusion bodies, were the cause of 
stippling seen in the thalassaemic cells. When fresh 
blood was obtained in Kermanshah and sent to 
Fig.1. Peptide map of ‘P’chain tryptic peptides of the pep- 
tides of the propositus’ haemoglobin. Electrophoresis at 
pH 6.4. Below flpXN another less hydrophobic peptide is 
seen. This peptide is additional to the peptides expected to 
be found in the p-chain fmgerprint. AE: aminoethylated. 
Cambridge no precipitate was obtained from the 
haemolysate, but on freezing and thawing it was 
noted that a faint precipitate developed which on cel- 
lulose acetate lectrophoresis remained at the origin. 
Fingerprints of the P-chain derived from globin of 
whole blood red cell lysate showed the abnormal 
peptide only very faintly, and it was just recognisable 
on staining for histidine. A considerably more deeply 
stained abnormal peptide was obtained when the 
globin was prepared from the lysate of reticulocyte 
enriched suspensions. 
In view of the distance of Kerrnanshah from 
Tehran it was not possible to conduct an adequate 
family study. One anaernic sister of the propositus 
however showed almost identical haematological 
features (see table 1) with an cv/nona globin synthesis 
of 0.8. She also possessed a pTpXIV companion pep- 
tide typical for Hb Coventry and there was again a 
difference in the quantity of the abnormal peptide 
Table 2 
Ammo acid composition of the less hydrophobic companion 
peptide of pATp XN (see fgl) 
Amino acid 
Abnormal peptide 
run01 molar ratio 
Expected for 
flATp XN 
Aspa 1.46 1.04 1 
CLY 1.76 1.25 1 
Aia 5.18 3.67 4 
Val 3.87 2.74 3 
His 1.46 1.04 1 
LYS 1.76 1.25 1 
Leu 0 0 1 
a From the electrophoretic properties of the peptide it can be 
concluded that this Asp is derived from Asn which has been 
deamidated uring the hydrolysis of the peptide which pre- 
cedes amino acid analysis 
The peptide has the amino acid composition of pATp XIV, 
except that one residue of leucine is missing 
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when fingerprints were compared from whole blood References 
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globin and from globin derived from reticulocytes 
and young erythrocytes. 111 
4. Discussion 
The straightforward heterozygote for the Hb 
PI 
131 
Coventry showed no haematological symptoms and 
the variant was discovered fortuitously in the pro- 
positus because of its co-precipitation with the unstable 
Hb Sydney which was also present [1] . It seems that .’ 
in the present case the cu-thalassaemia associated with 
an imbalance of polypeptide chains assisted in the 
preferential precipitation of Hb Coventry and per- 
mitted its subsequent identification. As stated on the 
first occasion [l] , one wonders whether this and 
similar haemoglobin variants might not be more 
frequent han is at present realised. 
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